Blog | Multibagger Shares

April 10, 2026

Hero image: article title 'The Dunning-Kruger Effect in Investing' with subtitle and a four-panel infographic showing Lucky, Disciplined Investor, Confused, and Bias-Trapped.

The Dunning-Kruger Effect in Investing: Why the Most Confident Traders Are Almost Always Wrong — And How Humble Value Investors Quietly Build Generational Wealth

SEBI data shows 9 out of 10 F&O traders lose money — the Dunning-Kruger effect explains why overconfident retail traders consistently blow up while humble value investors compound wealth for decades. Learn the 5 practical habits to escape Mount Stupid.

April 10, 2026

Infographic: Sum-of-the-Parts Valuation with horizontal bars for FY20–FY25; bars show values 38, 32, 26, 22, 19, and 16; FY25 bar is green on a dark blue background.

Sum-of-the-Parts Valuation: How Smart Indian Value Investors Unlock Hidden Value in Conglomerates Like ITC, Reliance, and Grasim — The Underused Valuation Method That Reveals True Worth When P/E Ratios Lie and Market Caps Mislead

How smart Indian value investors use Sum-of-the-Parts (SOTP) valuation to unlock hidden value in conglomerates like ITC, Bajaj Finserv, and Grasim — the underused valuation method that reveals what blended P/E ratios completely miss.

April 10, 2026

Annual bar chart showing declining figures from FY20 to FY25, with FY25 highlighted in green (FY20 28, FY21 26, FY22 22, FY23 18, FY24 14, FY25 11).

Bajaj Finance Transformation: The ₹10,000 That Became ₹3.23 Lakh — How Rajeev Jain’s 8 Strategic Pivots Turned a Sleepy Two-Wheeler Lender Into India’s Most Valuable NBFC and the Permanent Value Investing Lessons Every Indian Investor Must Learn Before Their Next Multibagger Hunt

📅 Published April 10, 2026 (Friday) The ₹10,000 That Became ₹3.23 Lakh: Why Bajaj Finance Is the Greatest NBFC Wealth Creation Story in Indian History Every […]

April 10, 2026

Hero banner titled 'Pharma Sector Analysis Framework' with four colored blocks: Trader (gray), Compounder (green), Drift (light gray), Speculator (orange).

Pharma Sector Analysis Framework: The 8-Factor Checklist Every Indian Value Investor Must Use to Separate Quality Pharmaceutical Multibaggers from Regulatory Time Bombs — A Complete Guide to India’s Most Lucrative and Most Complex Sector

The complete 8-factor pharma sector analysis framework for Indian value investors. Learn how to separate quality pharma multibaggers from regulatory time bombs using business model classification, regulatory risk profiling, revenue quality, R&D productivity, margin structure, balance sheet strength, capital allocation, and model-specific valuation.